News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,094 Results
Type
Article (88167)
Company Profile (825)
Press Release (784082)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18432)
Job Trends (17439)
News (398113)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (163)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (376)
Approvals (18632)
Artificial intelligence (676)
Autoimmune disease (191)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (175)
Brain cancer (69)
Breast cancer (694)
Cancer (5317)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77379)
Collaboration (1940)
Company closure (5)
Compensation (1225)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (957)
Cystic fibrosis (155)
Data (6652)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7319)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100702)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135783)
Executive appointments (1069)
FDA (21788)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1635)
Gene editing (230)
Generative AI (71)
Gene therapy (714)
GLP-1 (1166)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (90)
Immunology and inflammation (309)
Immuno-oncology (75)
Indications (131)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (396)
Machine learning (48)
Management (66)
Manufacturing (917)
MASH (182)
Medical device (15087)
Medtech (15151)
Mergers & acquisitions (23037)
Metabolic disorders (1473)
mRNA (201)
Multiple sclerosis (178)
NASH (23)
Neurodegenerative disease (383)
Neuropsychiatric disorders (108)
Neuroscience (3240)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (720)
Opinion (347)
Ovarian cancer (174)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (317)
Partnered (39)
Patents (545)
Patient recruitment (547)
Peanut (65)
People (67136)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23908)
Phase 2 (33576)
Phase 3 (25298)
Pipeline (5999)
Policy (357)
Postmarket research (3554)
Preclinical (10722)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (317)
Rare diseases (1003)
Real estate (7445)
Recruiting (81)
Regulatory (29327)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (93)
Last 7 days (983)
Last 30 days (2969)
Last 365 days (32727)
2026 (5407)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51685)
Australia (9083)
California (12155)
Canada (3462)
China (1227)
Colorado (514)
Connecticut (526)
Delaware (361)
Europe (118918)
Florida (1804)
Georgia (394)
Hawaii (4)
Idaho (68)
Illinois (1010)
India (80)
Indiana (574)
Iowa (24)
Japan (465)
Kansas (135)
Kentucky (47)
Louisiana (32)
Maine (84)
Maryland (1509)
Massachusetts (8899)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3266)
New Mexico (33)
New York (3203)
North Carolina (1676)
North Dakota (10)
Northern California (5877)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2418)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4707)
Tennessee (185)
Texas (1909)
United States (43701)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,094 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
March 2, 2026
·
7 min read
Press Releases
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
March 2, 2026
·
17 min read
Press Releases
Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments
March 2, 2026
·
9 min read
Press Releases
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
March 2, 2026
·
7 min read
Press Releases
Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening
March 2, 2026
·
2 min read
Press Releases
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
March 2, 2026
·
12 min read
Press Releases
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
March 2, 2026
·
11 min read
Press Releases
Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date
March 2, 2026
·
10 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - March 2, 2026
March 2, 2026
·
2 min read
Press Releases
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 2, 2026
·
28 min read
1 of 87,310
Next
